Article
Interleukin-17 haplotyping predicts hepatocellular carcinoma in sofosbuvir, pegylated interferon-alpha-2a & ribavirin treated chronic hepatitis C patients.
Virus research - 15 Jan 2021
Mostafa Ahmed M, Saafan Hesham A, Al-Tawashi Ahmed S, Kasem Muhannad H, Alaa Ahmed M, Eltobgy Mahmoud M, Moubarak Ahmed S, Gharib Manar M, Awwad Mohamed A, Omar Hazem M, El-Derany Marwa O
Abstract excerpt
Suspect has been directed towards some direct acting antivirals (DAAs) due to their reported association with hepatocellular carcinoma (HCC) development in chronic hepatitis C (CHC) patients. The mechanisms behind HCC development, following CHC treatment, were not well understood and may be linked to genetic variabilities in different patients which affect several cytokine productions involved in angiogenesis and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
